AstraZeneca PLC (LON:0A4J)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,488	5,840	6,166	6,329	7,832
Short-Term Investments	-	-	64	53	42
Trading Asset Securities	37	20	14	16	161
Cash & Short-Term Investments	5,525	5,860	6,244	6,398	8,035
Cash Growth	-5.72%	-6.15%	-2.41%	-20.37%	29.22%
Accounts Receivable	8,302	8,407	7,212	6,031	3,806
Other Receivables	4,792	3,528	2,711	2,764	1,845
Receivables	13,094	11,935	9,923	8,795	5,651
Inventory	5,288	5,424	4,699	8,983	4,024
Prepaid Expenses	1,737	1,617	1,329	1,512	1,735
Restricted Cash	129	102	162	-	-
Other Current Assets	54	116	236	556	99
Total Current Assets	25,827	25,054	22,593	26,244	19,544
Property, Plant & Equipment	11,647	10,502	9,449	10,171	8,917
Long-Term Investments	1,900	1,677	1,142	1,262	1,192
Goodwill	21,025	20,048	19,820	19,997	11,845
Other Intangible Assets	37,177	38,089	39,307	42,387	20,947
Long-Term Deferred Tax Assets	5,347	4,718	3,263	4,330	3,438
Other Long-Term Assets	1,112	1,031	909	972	846
Total Assets	104,035	101,119	96,483	105,363	66,729
Accounts Payable	3,640	3,267	2,550	2,824	2,350
Accrued Expenses	16,088	15,845	13,514	12,358	9,689
Short-Term Debt	330	515	350	411	661
Current Portion of Long-Term Debt	2,057	5,603	5,924	2,248	1,566
Current Portion of Leases	339	271	228	233	192
Current Income Taxes Payable	1,406	1,584	896	916	1,127
Current Unearned Revenue	126	149	182	1,181	1,958
Other Current Liabilities	3,880	3,308	2,649	2,423	2,764
Total Current Liabilities	27,866	30,542	26,293	22,594	20,307
Long-Term Debt	26,621	22,403	23,908	29,717	19,804
Long-Term Leases	1,113	857	725	754	489
Long-Term Unearned Revenue	-	7	14	26	38
Long-Term Deferred Tax Liabilities	3,305	2,844	2,944	6,206	2,918
Other Long-Term Liabilities	2,929	3,780	4,373	4,325	4,333
Total Liabilities	63,164	61,953	59,425	66,076	51,091
Common Stock	388	388	387	387	328
Additional Paid-In Capital	35,226	35,188	35,155	35,126	7,971
Retained Earnings	7,229	4,516	3,120	3,644	6,442
Comprehensive Income & Other	-2,057	-949	-1,625	111	881
Total Common Equity	40,786	39,143	37,037	39,268	15,622
Minority Interest	85	23	21	19	16
Shareholders' Equity	40,871	39,166	37,058	39,287	15,638
Total Liabilities & Equity	104,035	101,119	96,483	105,363	66,729
Total Debt	30,460	29,649	31,135	33,363	22,712
Net Cash (Debt)	-24,935	-23,789	-24,891	-26,965	-14,677
Net Cash Per Share	-15.95	-15.23	-15.96	-18.90	-11.18
Filing Date Shares Outstanding	1,551	1,550	1,550	1,549	1,313
Total Common Shares Outstanding	1,551	1,550	1,550	1,549	1,313
Working Capital	-2,039	-5,488	-3,700	3,650	-763
Book Value Per Share	26.30	25.25	23.90	25.34	11.90
Tangible Book Value	-17,416	-18,994	-22,090	-23,116	-17,170
Tangible Book Value Per Share	-11.23	-12.25	-14.25	-14.92	-13.08
Land	6,580	6,469	5,440	6,377	5,851
Machinery	8,854	8,704	7,556	7,903	7,738
Construction In Progress	2,789	2,045	2,653	2,728	2,478

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.